カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の吸入コルチコステロイド市場2022年：ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他

◆英語タイトル：Global Inhaled Corticosteroid Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8858）◆商品コード：GIR22MY8858
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：109
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

吸入コルチコステロイド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の吸入コルチコステロイドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

吸入コルチコステロイド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、呼吸ケアセンター、その他

世界の吸入コルチコステロイド市場の主要な市場プレーヤーは以下のとおりです。
・Sumitomo、Pfizer、Novartis、Merck、Sanofi、Johnson and Johnson、GSK、AstraZeneca、Teijin、Glaxo's Advair、Amgen、Kos Pharmaceutical、Teva Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、吸入コルチコステロイド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な吸入コルチコステロイドメーカーの企業概要、2019年～2022年までの吸入コルチコステロイドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な吸入コルチコステロイドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別吸入コルチコステロイドの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの吸入コルチコステロイドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での吸入コルチコステロイド市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および吸入コルチコステロイドの産業チェーンを掲載しています。
・第13、14、15章では、吸入コルチコステロイドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sumitomo、Pfizer、Novartis、Merck、Sanofi、Johnson and Johnson、GSK、AstraZeneca、Teijin、Glaxo's Advair、Amgen、Kos Pharmaceutical、Teva Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他
・用途別分析2017年-2028年：病院、クリニック、呼吸ケアセンター、その他
・吸入コルチコステロイドの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・吸入コルチコステロイドのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・吸入コルチコステロイドのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・吸入コルチコステロイドの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・吸入コルチコステロイドの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Inhaled Corticosteroid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Inhaled Corticosteroid market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Inhaled Corticosteroid global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Beclomethasone Dipropionate segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Inhaled Corticosteroid include Sumitomo, Pfizer, Novartis, Merck, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Inhaled Corticosteroid market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
Market segment by Application can be divided into
Hospitals
Clinics
Respiratory Care Centers
Others
The key market players for global Inhaled Corticosteroid market are listed below:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo’s Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaled Corticosteroid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhaled Corticosteroid, with price, sales, revenue and global market share of Inhaled Corticosteroid from 2019 to 2022.
Chapter 3, the Inhaled Corticosteroid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Corticosteroid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Inhaled Corticosteroid market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inhaled Corticosteroid.
Chapter 13, 14, and 15, to describe Inhaled Corticosteroid sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Inhaled Corticosteroid Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhaled Corticosteroid Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Beclomethasone Dipropionate
1.2.3 Budesonide
1.2.4 Fluticasone Inhaler Powder
1.2.5 Mometasone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhaled Corticosteroid Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Global Inhaled Corticosteroid Market Size & Forecast
1.4.1 Global Inhaled Corticosteroid Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inhaled Corticosteroid Sales in Volume (2017-2028)
1.4.3 Global Inhaled Corticosteroid Price (2017-2028)
1.5 Global Inhaled Corticosteroid Production Capacity Analysis
1.5.1 Global Inhaled Corticosteroid Total Production Capacity (2017-2028)
1.5.2 Global Inhaled Corticosteroid Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inhaled Corticosteroid Market Drivers
1.6.2 Inhaled Corticosteroid Market Restraints
1.6.3 Inhaled Corticosteroid Trends Analysis
2 Manufacturers Profiles
2.1 Sumitomo
2.1.1 Sumitomo Details
2.1.2 Sumitomo Major Business
2.1.3 Sumitomo Inhaled Corticosteroid Product and Services
2.1.4 Sumitomo Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Inhaled Corticosteroid Product and Services
2.2.4 Pfizer Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Inhaled Corticosteroid Product and Services
2.3.4 Novartis Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Inhaled Corticosteroid Product and Services
2.4.4 Merck Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Inhaled Corticosteroid Product and Services
2.5.4 Sanofi Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Inhaled Corticosteroid Product and Services
2.6.4 Johnson and Johnson Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Inhaled Corticosteroid Product and Services
2.7.4 GSK Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Inhaled Corticosteroid Product and Services
2.8.4 AstraZeneca Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Teijin
2.9.1 Teijin Details
2.9.2 Teijin Major Business
2.9.3 Teijin Inhaled Corticosteroid Product and Services
2.9.4 Teijin Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Glaxo’s Advair
2.10.1 Glaxo’s Advair Details
2.10.2 Glaxo’s Advair Major Business
2.10.3 Glaxo’s Advair Inhaled Corticosteroid Product and Services
2.10.4 Glaxo’s Advair Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Inhaled Corticosteroid Product and Services
2.11.4 Amgen Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Kos Pharmaceutical
2.12.1 Kos Pharmaceutical Details
2.12.2 Kos Pharmaceutical Major Business
2.12.3 Kos Pharmaceutical Inhaled Corticosteroid Product and Services
2.12.4 Kos Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Teva Pharmaceutical
2.13.1 Teva Pharmaceutical Details
2.13.2 Teva Pharmaceutical Major Business
2.13.3 Teva Pharmaceutical Inhaled Corticosteroid Product and Services
2.13.4 Teva Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Inhaled Corticosteroid Breakdown Data by Manufacturer
3.1 Global Inhaled Corticosteroid Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inhaled Corticosteroid Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inhaled Corticosteroid
3.4 Market Concentration Rate
3.4.1 Top 3 Inhaled Corticosteroid Manufacturer Market Share in 2021
3.4.2 Top 6 Inhaled Corticosteroid Manufacturer Market Share in 2021
3.5 Global Inhaled Corticosteroid Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inhaled Corticosteroid Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inhaled Corticosteroid Market Size by Region
4.1.1 Global Inhaled Corticosteroid Sales in Volume by Region (2017-2028)
4.1.2 Global Inhaled Corticosteroid Revenue by Region (2017-2028)
4.2 North America Inhaled Corticosteroid Revenue (2017-2028)
4.3 Europe Inhaled Corticosteroid Revenue (2017-2028)
4.4 Asia-Pacific Inhaled Corticosteroid Revenue (2017-2028)
4.5 South America Inhaled Corticosteroid Revenue (2017-2028)
4.6 Middle East and Africa Inhaled Corticosteroid Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Inhaled Corticosteroid Sales in Volume by Type (2017-2028)
5.2 Global Inhaled Corticosteroid Revenue by Type (2017-2028)
5.3 Global Inhaled Corticosteroid Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Inhaled Corticosteroid Sales in Volume by Application (2017-2028)
6.2 Global Inhaled Corticosteroid Revenue by Application (2017-2028)
6.3 Global Inhaled Corticosteroid Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Inhaled Corticosteroid Sales by Type (2017-2028)
7.2 North America Inhaled Corticosteroid Sales by Application (2017-2028)
7.3 North America Inhaled Corticosteroid Market Size by Country
7.3.1 North America Inhaled Corticosteroid Sales in Volume by Country (2017-2028)
7.3.2 North America Inhaled Corticosteroid Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Inhaled Corticosteroid Sales by Type (2017-2028)
8.2 Europe Inhaled Corticosteroid Sales by Application (2017-2028)
8.3 Europe Inhaled Corticosteroid Market Size by Country
8.3.1 Europe Inhaled Corticosteroid Sales in Volume by Country (2017-2028)
8.3.2 Europe Inhaled Corticosteroid Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Inhaled Corticosteroid Sales by Type (2017-2028)
9.2 Asia-Pacific Inhaled Corticosteroid Sales by Application (2017-2028)
9.3 Asia-Pacific Inhaled Corticosteroid Market Size by Region
9.3.1 Asia-Pacific Inhaled Corticosteroid Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inhaled Corticosteroid Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Inhaled Corticosteroid Sales by Type (2017-2028)
10.2 South America Inhaled Corticosteroid Sales by Application (2017-2028)
10.3 South America Inhaled Corticosteroid Market Size by Country
10.3.1 South America Inhaled Corticosteroid Sales in Volume by Country (2017-2028)
10.3.2 South America Inhaled Corticosteroid Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inhaled Corticosteroid Sales by Type (2017-2028)
11.2 Middle East & Africa Inhaled Corticosteroid Sales by Application (2017-2028)
11.3 Middle East & Africa Inhaled Corticosteroid Market Size by Country
11.3.1 Middle East & Africa Inhaled Corticosteroid Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inhaled Corticosteroid Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Inhaled Corticosteroid and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inhaled Corticosteroid
12.3 Inhaled Corticosteroid Production Process
12.4 Inhaled Corticosteroid Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inhaled Corticosteroid Typical Distributors
13.3 Inhaled Corticosteroid Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Inhaled Corticosteroid Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Inhaled Corticosteroid Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sumitomo Basic Information, Manufacturing Base and Competitors
Table 4. Sumitomo Major Business
Table 5. Sumitomo Inhaled Corticosteroid Product and Services
Table 6. Sumitomo Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Inhaled Corticosteroid Product and Services
Table 10. Pfizer Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Inhaled Corticosteroid Product and Services
Table 14. Novartis Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Inhaled Corticosteroid Product and Services
Table 18. Merck Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Inhaled Corticosteroid Product and Services
Table 22. Sanofi Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson and Johnson Major Business
Table 25. Johnson and Johnson Inhaled Corticosteroid Product and Services
Table 26. Johnson and Johnson Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GSK Basic Information, Manufacturing Base and Competitors
Table 28. GSK Major Business
Table 29. GSK Inhaled Corticosteroid Product and Services
Table 30. GSK Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Inhaled Corticosteroid Product and Services
Table 34. AstraZeneca Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Teijin Basic Information, Manufacturing Base and Competitors
Table 36. Teijin Major Business
Table 37. Teijin Inhaled Corticosteroid Product and Services
Table 38. Teijin Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Glaxo's Advair Basic Information, Manufacturing Base and Competitors
Table 40. Glaxo's Advair Major Business
Table 41. Glaxo's Advair Inhaled Corticosteroid Product and Services
Table 42. Glaxo's Advair Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Amgen Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Major Business
Table 45. Amgen Inhaled Corticosteroid Product and Services
Table 46. Amgen Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Kos Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Kos Pharmaceutical Major Business
Table 49. Kos Pharmaceutical Inhaled Corticosteroid Product and Services
Table 50. Kos Pharmaceutical Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Teva Pharmaceutical Major Business
Table 53. Teva Pharmaceutical Inhaled Corticosteroid Product and Services
Table 54. Teva Pharmaceutical Inhaled Corticosteroid Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Inhaled Corticosteroid Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 56. Global Inhaled Corticosteroid Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Inhaled Corticosteroid, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Inhaled Corticosteroid Production Capacity by Company, (MT): 2020 VS 2021
Table 59. Head Office and Inhaled Corticosteroid Production Site of Key Manufacturer
Table 60. Inhaled Corticosteroid New Entrant and Capacity Expansion Plans
Table 61. Inhaled Corticosteroid Mergers & Acquisitions in the Past Five Years
Table 62. Global Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
Table 63. Global Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
Table 64. Global Inhaled Corticosteroid Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Inhaled Corticosteroid Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 67. Global Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 68. Global Inhaled Corticosteroid Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Inhaled Corticosteroid Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Inhaled Corticosteroid Price by Type (2017-2022) & (USD/MT)
Table 71. Global Inhaled Corticosteroid Price by Type (2023-2028) & (USD/MT)
Table 72. Global Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 73. Global Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 74. Global Inhaled Corticosteroid Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Inhaled Corticosteroid Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Inhaled Corticosteroid Price by Application (2017-2022) & (USD/MT)
Table 77. Global Inhaled Corticosteroid Price by Application (2023-2028) & (USD/MT)
Table 78. North America Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 79. North America Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 80. North America Inhaled Corticosteroid Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Inhaled Corticosteroid Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 83. North America Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 84. North America Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 85. North America Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 86. Europe Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 87. Europe Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 88. Europe Inhaled Corticosteroid Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Inhaled Corticosteroid Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 91. Europe Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 92. Europe Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 93. Europe Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 94. Asia-Pacific Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
Table 95. Asia-Pacific Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
Table 96. Asia-Pacific Inhaled Corticosteroid Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Inhaled Corticosteroid Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 99. Asia-Pacific Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 100. Asia-Pacific Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 101. Asia-Pacific Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 102. South America Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 103. South America Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 104. South America Inhaled Corticosteroid Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Inhaled Corticosteroid Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 107. South America Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 108. South America Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 109. South America Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 110. Middle East & Africa Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
Table 111. Middle East & Africa Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
Table 112. Middle East & Africa Inhaled Corticosteroid Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Inhaled Corticosteroid Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 115. Middle East & Africa Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 116. Middle East & Africa Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 117. Middle East & Africa Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 118. Inhaled Corticosteroid Raw Material
Table 119. Key Manufacturers of Inhaled Corticosteroid Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Inhaled Corticosteroid Typical Distributors
Table 123. Inhaled Corticosteroid Typical Customers
List of Figures
Figure 1. Inhaled Corticosteroid Picture
Figure 2. Global Inhaled Corticosteroid Revenue Market Share by Type in 2021
Figure 3. Beclomethasone Dipropionate
Figure 4. Budesonide
Figure 5. Fluticasone Inhaler Powder
Figure 6. Mometasone
Figure 7. Others
Figure 8. Global Inhaled Corticosteroid Revenue Market Share by Application in 2021
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Respiratory Care Centers
Figure 12. Others
Figure 13. Global Inhaled Corticosteroid Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 14. Global Inhaled Corticosteroid Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Inhaled Corticosteroid Sales (2017-2028) & (MT)
Figure 16. Global Inhaled Corticosteroid Price (2017-2028) & (USD/MT)
Figure 17. Global Inhaled Corticosteroid Production Capacity (2017-2028) & (MT)
Figure 18. Global Inhaled Corticosteroid Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Inhaled Corticosteroid Market Drivers
Figure 20. Inhaled Corticosteroid Market Restraints
Figure 21. Inhaled Corticosteroid Market Trends
Figure 22. Global Inhaled Corticosteroid Sales Market Share by Manufacturer in 2021
Figure 23. Global Inhaled Corticosteroid Revenue Market Share by Manufacturer in 2021
Figure 24. Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Inhaled Corticosteroid Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Inhaled Corticosteroid Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Inhaled Corticosteroid Sales Market Share by Region (2017-2028)
Figure 28. Global Inhaled Corticosteroid Revenue Market Share by Region (2017-2028)
Figure 29. North America Inhaled Corticosteroid Revenue (2017-2028) & (USD Million)
Figure 30. Europe Inhaled Corticosteroid Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Inhaled Corticosteroid Revenue (2017-2028) & (USD Million)
Figure 32. South America Inhaled Corticosteroid Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Inhaled Corticosteroid Revenue (2017-2028) & (USD Million)
Figure 34. Global Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 35. Global Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 36. Global Inhaled Corticosteroid Price by Type (2017-2028) & (USD/MT)
Figure 37. Global Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 38. Global Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 39. Global Inhaled Corticosteroid Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 41. North America Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 42. North America Inhaled Corticosteroid Sales Market Share by Country (2017-2028)
Figure 43. North America Inhaled Corticosteroid Revenue Market Share by Country (2017-2028)
Figure 44. United States Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 48. Europe Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 49. Europe Inhaled Corticosteroid Sales Market Share by Country (2017-2028)
Figure 50. Europe Inhaled Corticosteroid Revenue Market Share by Country (2017-2028)
Figure 51. Germany Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Inhaled Corticosteroid Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Inhaled Corticosteroid Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Inhaled Corticosteroid Revenue Market Share by Region (2017-2028)
Figure 60. China Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 67. South America Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 68. South America Inhaled Corticosteroid Sales Market Share by Country (2017-2028)
Figure 69. South America Inhaled Corticosteroid Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Inhaled Corticosteroid Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Inhaled Corticosteroid Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Inhaled Corticosteroid in 2021
Figure 81. Manufacturing Process Analysis of Inhaled Corticosteroid
Figure 82. Inhaled Corticosteroid Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の吸入コルチコステロイド市場2022年：ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他(Global Inhaled Corticosteroid Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • コルチコステロイド反応性疾患のグローバル市場2023年：注射、経口
  • 血管炎治療の世界市場2022年～2029年：治療薬クラス別、疾患別、流通チャネル別、地域別
  • 世界の吸入式一酸化窒素デリバリー装置市場インサイト及び予測（子供用吸入一酸化窒素デリバリー装置、成人用吸入一酸化窒素デリバリー装置）
  • 世界のBGM（血糖測定）＆CGM（持続血糖測定）市場2022年：血糖測定、持続血糖測定
  • 世界の携帯型レスピレーター市場2022年：定圧式レスピレーター、定容量式レスピレーター、タイミング式レスピレーター、混合式レスピレーター